In this video, Dr. Brian G.M. Durie explains how high-dose melphalan therapy that precedes an ASCT may cause some side effects and how an ASCT itself may result in some low-risk complications.
The BOTTOM LINE: Autologous stem cell transplant is still a recommended therapy, if feasible, and it is mostly manageable.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: bit.ly/XlUtPE
Visit our website at: www.myeloma.org
Find us online:
Facebook: / myeloma
Google+: gplus.to/imfmye...
IMF on twitter: @IMFMyeloma ( / imfmyeloma )
Dr. Durie on twitter: @BrianDurieMD ( / brianduriemd )
Support the IMF! bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard KZfaq License